DermTech

Melanoma and Skin Cancer Detection - DermTech.

Launch date

1996

Employees

Market cap

Enterprise valuation

AUD28m (Public information from Jun 2024)

San Diego California (HQ)

http://dermtech.com

https://twitter.com/dermtech https://www.facebook.com/dermtech https://www.linkedin.com/company/dermtech

View job openings

Revenues, earnings & profits over time

USD	2019	2020	2021	2022	2023	2024	2025
Revenues	3.4m	5.9m	11.8m	14.5m	15.3m	17.6m	20.6m
% growth	(77 %)	75 %	101 %	23 %	5 %	15 %	17 %
EBITDA	(18.0m)	(35.3m)	(76.3m)	(118m)	(97.9m)	-	-
% EBITDA margin	(534 %)	(600 %)	(645 %)	(815 %)	(640 %)	-	-
Profit	(19.7m)	(35.2m)	(78.3m)	(117m)	(101m)	-	-
% profit margin	(585 %)	(599 %)	(662 %)	(804 %)	(660 %)	-	-
R&D budget	2.5m	5.3m	16.3m	24.1m	15.2m	-	-
R&D % of revenue	74 %	90 %	137 %	166 %	100 %	-	-

Date	Investors	Amount	Round
-	HLM Venture Partners	N/A	-
Jun 1998	N/A	N/A	Early VC
Mar 2008	N/A	$11.2m	Early VC
Nov 2008	Valeant Pharmaceuticals International	$19.0m Valuation: $19.0m	Acquisition
Apr 2012	N/A	$11.6m	Early VC
Aug 2013	N/A	$5.6m	Series B
Apr 2015	N/A	$2.4m	Debt
Nov 2015	N/A	$4.3m	Early VC
Oct 2016	N/A	$2.1m	Early VC
Aug 2017	N/A	N/A	IPO
Nov 2017	N/A	$10.0m	Series C
Aug 2019	N/A	$4.0m	Post IPO Equity
Mar 2020	N/A	$65.0m	Post IPO Equity
Jan 2021*	N/A	$144m	Post IPO Equity
Sep 2024*	N/A	N/A	Acquisition
Total Funding		AUD69.2m

Tech stackLearn more about the technologies and tools that this company uses.